• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞中 PD-1 和 GITR 的表型变化与乙型肝炎表面抗原血清学清除相关。

Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen Seroclearance.

机构信息

Department of Medicine, The University of Hong Kong.

State Key Laboratory for Liver Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

出版信息

J Clin Gastroenterol. 2022 Jan 1;56(1):e31-e37. doi: 10.1097/MCG.0000000000001461.

DOI:10.1097/MCG.0000000000001461
PMID:33122602
Abstract

BACKGROUND

Regulatory T cells (Tregs) possess hepatitis B virus (HBV)-specific immunoregulatory effects in chronic HBV infection. The role of Tregs in spontaneous seroclearance of hepatitis B surface antigen (HBsAg) remains to be determined.

METHODS

We recruited treatment-naive chronic HBV patients achieving spontaneous HBsAg seroclearance (experimental group) and matched HBsAg-positive controls. Peripheral blood mononuclear cells were isolated using the Ficoll-Paque density gradient centrifugation method. The frequency of Tregs and inhibitory phenotypes and immunoregulatory cytokines of Tregs were detected by flow cytometry.

RESULTS

Twenty-seven patients with HBsAg seroclearance (mean age: 52.40±6.00 y, 55.6% male) and 27 matched controls were recruited. Median HBsAg and HBV DNA levels in the control group were 2.80 (1.24 to 3.43) and 3.16 (1.68 to 3.85) log IU/mL, respectively. Mean frequencies of Tregs and expressions of FoxP3+ Tregs were comparable in both groups (both P>0.05). The mean expression of programmed death 1 (PD-1) and glucocorticoid-induced TNFR family-related gene (GITR) in total CD4+ T cells were significantly downregulated in the experimental group when compared with the control group (10.62% vs. 13.85%, P=0.003; 16.20% vs. 27.02%, P=0.002, respectively). When compared with the control group, PD-1+CD4+ Tregs expression in the experimental group was significantly downregulated (13.85% vs. 10.62%, P=0.003). A similar phenomenon was noted for GITR+CD8+ Tregs (20.16% vs. 14.08%, P=0.049). Intracellular cytokine productions showed no significant differences (all P>0.05).

CONCLUSIONS

The reduced expression of PD-1 and GITR might attenuate the immunosuppressive capability of Tregs. Decreased expression on CD4+ T cells might represent an enhanced antiviral function, playing a role in initiating the "functional cure" of chronic HBV infection.

摘要

背景

调节性 T 细胞(Tregs)在慢性乙型肝炎病毒(HBV)感染中具有 HBV 特异性免疫调节作用。Tregs 在乙型肝炎表面抗原(HBsAg)自发清除中的作用仍有待确定。

方法

我们招募了未经治疗的慢性 HBV 患者,这些患者实现了 HBsAg 血清学清除(实验组),并匹配了 HBsAg 阳性对照。使用 Ficoll-Paque 密度梯度离心法分离外周血单核细胞。通过流式细胞术检测 Tregs 的频率以及 Tregs 的抑制表型和免疫调节细胞因子。

结果

招募了 27 例 HBsAg 血清学清除患者(平均年龄:52.40±6.00 岁,55.6%为男性)和 27 例匹配对照。对照组的 HBsAg 和 HBV DNA 中位数水平分别为 2.80(1.24 至 3.43)和 3.16(1.68 至 3.85)log IU/mL。两组的 Tregs 频率和 FoxP3+Tregs 的表达均无差异(均 P>0.05)。与对照组相比,实验组总 CD4+T 细胞中程序性死亡 1(PD-1)和糖皮质激素诱导的 TNFR 家族相关基因(GITR)的平均表达显著下调(10.62%比 13.85%,P=0.003;16.20%比 27.02%,P=0.002,分别)。与对照组相比,实验组 PD-1+CD4+Tregs 的表达显著下调(13.85%比 10.62%,P=0.003)。GITR+CD8+Tregs 也出现类似现象(20.16%比 14.08%,P=0.049)。细胞内细胞因子产生无显著差异(均 P>0.05)。

结论

PD-1 和 GITR 的表达减少可能会削弱 Tregs 的免疫抑制能力。CD4+T 细胞上表达的减少可能代表抗病毒功能增强,在启动慢性 HBV 感染的“功能性治愈”中发挥作用。

相似文献

1
Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen Seroclearance.T 细胞中 PD-1 和 GITR 的表型变化与乙型肝炎表面抗原血清学清除相关。
J Clin Gastroenterol. 2022 Jan 1;56(1):e31-e37. doi: 10.1097/MCG.0000000000001461.
2
Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.在接受替诺福韦酯治疗的慢性乙型肝炎病毒感染患者中,循环 Tregs 与病毒载量降低相关。
J Clin Immunol. 2011 Jun;31(3):509-20. doi: 10.1007/s10875-011-9509-7. Epub 2011 Feb 9.
3
Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.乙肝 e 抗原血清学清除后乙肝表面抗原水平:一项纵向随访研究。
Liver Int. 2015 Mar;35(3):854-9. doi: 10.1111/liv.12596. Epub 2014 Jun 4.
4
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.在接受阿德福韦治疗的乙型肝炎病毒(HBV)感染者及HIV/HBV合并感染者中,通过程序性死亡受体-1/程序性死亡受体配体-1阻断增强HBV特异性细胞免疫。
AIDS Res Hum Retroviruses. 2013 Apr;29(4):665-72. doi: 10.1089/AID.2012.0320. Epub 2013 Feb 11.
5
Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy.抗病毒治疗诱导乙型肝炎表面抗原血清学清除患者的细胞免疫应答。
Virol J. 2011 Feb 14;8:69. doi: 10.1186/1743-422X-8-69.
6
[Observation of PD-1CXCR5CD4T lymphocyte and sPD-1 levels in HBeAg positive chronic hepatitis B virus carriers treated with entecavir].恩替卡韦治疗HBeAg阳性慢性乙型肝炎病毒携带者的PD-1、CXCR5、CD4+T淋巴细胞及可溶性PD-1水平观察
Zhonghua Gan Zang Bing Za Zhi. 2022 Mar 20;30(3):316-322. doi: 10.3760/cma.j.cn501113-20191223-00476.
7
Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.慢性乙型肝炎感染患者的乙肝表面抗原血清学清除:一项临床研究。
J Int Med Res. 2013 Oct;41(5):1732-9. doi: 10.1177/0300060513487643. Epub 2013 Aug 1.
8
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.台湾地区慢性 HBV/HCV 合并感染患者接受直接作用抗病毒治疗后的乙型肝炎相关结局。
J Hepatol. 2020 Jul;73(1):62-71. doi: 10.1016/j.jhep.2020.01.027. Epub 2020 Feb 14.
9
Circulating PD-1CXCR5CD4 T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy.循环 PD-1+CXCR5+CD4+T 细胞与接受聚乙二醇干扰素-α治疗的慢性乙型肝炎患者乙型肝炎表面抗原水平下降相关。
Mol Immunol. 2018 Nov;103:270-278. doi: 10.1016/j.molimm.2018.10.011. Epub 2018 Oct 16.
10
Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation.乙肝再激活患者乙肝表面抗原血清学转换的免疫预测指标
Aliment Pharmacol Ther. 2023 Mar;57(6):689-708. doi: 10.1111/apt.17306. Epub 2022 Nov 21.

引用本文的文献

1
Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy.乙肝表面抗原血清学清除后的肝细胞癌:根治性肝切除术后的临床特征、复发及预后
Ther Adv Med Oncol. 2024 Oct 18;16:17588359241289202. doi: 10.1177/17588359241289202. eCollection 2024.
2
Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma.探索糖皮质激素诱导的肿瘤坏死因子受体(GITR)/糖皮质激素诱导的肿瘤坏死因子受体配体(GITRL)信号传导的作用:从肝脏疾病到肝细胞癌
Cancers (Basel). 2024 Jul 22;16(14):2609. doi: 10.3390/cancers16142609.
3
Recent advances in understanding T cell activation and exhaustion during HBV infection.
乙型肝炎病毒感染过程中 T 细胞激活和耗竭的研究进展。
Virol Sin. 2023 Dec;38(6):851-859. doi: 10.1016/j.virs.2023.10.007. Epub 2023 Oct 21.
4
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.慢性乙型肝炎病毒感染的免疫反应和治疗靶点:固有和适应性免疫。
Front Cell Infect Microbiol. 2023 Jun 22;13:1206720. doi: 10.3389/fcimb.2023.1206720. eCollection 2023.
5
Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.HBV 感染背景下的 T 细胞和 NK 细胞免疫检查点:全景、病理生理学和治疗开发。
Front Immunol. 2023 Mar 28;14:1148111. doi: 10.3389/fimmu.2023.1148111. eCollection 2023.